Atossa Therapeutics
ATOS
#10042
Rank
NZ$70.45 M
Marketcap
NZ$8.18
Share price
-1.44%
Change (1 day)
395.14%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -NZ$51.93 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$43.66 Million, an increase over its 2023 earnings that were of -NZ$51.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$51.93 Million18.95%
2024 -NZ$43.66 Million-15.25%
2023 -NZ$51.51 Million11.62%
2022 -NZ$46.15 Million30.84%
2021 -NZ$35.27 Million15.58%
2020 -NZ$30.52 Million3.41%
2019 -NZ$29.51 Million51.16%
2018 -NZ$19.53 Million40.41%
2017 -NZ$13.91 Million27.54%
2016 -NZ$10.91 Million-47.49%
2015 -NZ$20.76 Million-17.25%
2014 -NZ$25.09 Million35.91%
2013 -NZ$18.46 Million112.3%
2012 -NZ$8.7 Million46.53%
2011 -NZ$5.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.46 B-86,180.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.35 B-4,659.31%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.35 B-4,656.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$71.34 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-NZ$0.18 Billion 229.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-NZ$13.43 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA